PATENT CLAIM ANALYSIS

Application Number: 16150759
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "352000"]

Abstract:
A topical pharmaceutical preparation for administering a slightly soluble PDE4 inhibitor is described. A surprisingly good systemic bioavailability is observed with this dosage form.

Claim (Index 18):
A topically applicable pharmaceutical preparation consisting of an active pharmaceutical ingredient together with one or more pharmaceutical carriers or excipients suitable for topical administration;\n wherein the active pharmaceutical ingredient is selected from the group consisting of roflumilast, salts of roflumilast, the N-oxide of the pyridine residue of roflumilast and salts thereof; wherein the proportion of active pharmaceutical ingredient is up to 1% by weight of the topically applicable pharmaceutical preparation; and wherein the topically applicable pharmaceutical preparation is a semisolid dosage form selected from the group consisting of solution ointments, suspension ointments, creams, gels, and pastes.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 97.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11885837', '11662887', '10505138', '13008842', '15848505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7600637725768526
- 35 USC 102 Novelty (BERT): 0.4725386970863068
- Combined Prediction Score: 0.7313112650277981
- Mean Citation Score: 157.52345
- Max Citation Score: 179.21704
- Similarity Product: 140.05891467522144

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test